LivaNova PLC (LIVN)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Alex Shvartsburg | Chief Financial Officer | 1.2M | -- | 1970 |
| Mr. Michael D. Hutchinson | Senior VP, Chief Legal Officer & Company Secretary | 1.09M | -- | 1971 |
| Mr. Vladimir A. Makatsaria | CEO & Director | -- | -- | 1973 |
| Lindsey Little | Senior Director of Investor Relations | -- | -- | -- |
| Deanna Wilke | Vice President of Corporate Communications | -- | -- | -- |
| Mr. Matthew Joseph Dodds III | Senior Vice President of Corporate Development & IT | -- | -- | -- |
| Mr. Paul R. Buckman | President of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement | -- | -- | 1956 |
| Ms. Stephanie Bolton | President of Global Epilepsy | -- | -- | 1982 |
| Ahmet Tezel Ph.D. | Chief Innovation Officer | -- | -- | -- |
| Mr. Franco Poletti | President of Cardiopulmonary Business Unit | -- | -- | -- |
LivaNova PLC
- Sector:?
- Healthcare
- Industry:? Medical Devices
- Full Time Employees:?
- 2,900
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
Corporate Governance
Upcoming Events
October 30, 2024 at 8:30 AM UTC
LivaNova PLC Earnings Date
Recent Events
August 1, 2024 at 12:00 AM UTC
IRANNOTICE: Notice of disclosure filed in Exchange Act quarterly and annual reports pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act
May 31, 2024 at 12:00 AM UTC
SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)